跳至主要内容
临床试验/IRCT20190918044815N1
IRCT20190918044815N1已完成3 期

Evaluation of curcumin effect on prevention of hepatotoxicity induced by chemotherapeutic drugs in patients under outpatient canecr treatment

Esfahan University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
30 years 至 60 years(—)
性别
All

入选标准

  • •Age 30 to 60 years
  • •Definitive diagnosis of cancer that chemotherapyeutic treatment is indicated .
  • •Treated with a regimen containing paclitaxel and docetaxel
  • •Ability to take oral medication

排除标准

  • •Gastrointestinal bleeding
  • •pregnancy and Breastfeeding
  • •using heparin, aspirin, Clopidogrel, dipiridamol ,warfarin and ticlopidine
  • •Past medical history of hepatic disease
  • •Past medical history of peptic ulcer

研究者

相似试验